UBS analyst Michael Ward lowered the firm’s price target on Voya Financial (VOYA) to $87 from $90 and keeps a Buy rating on the shares. The firm adjusted targets in the North American life insurance group as part of a Q1 earnings preview. UBS expects continued focus on disability margins with “relatively limited wiggle-room” given cyclicality and economic uncertainty. The firm rolled its target to 2027 from 2026 estimates.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VOYA:
- Voya Financial Issues Preliminary Q1 2026 Investment Update
- Voya Financial sees Q1 alternative investment income of $35M-$45M
- Voya Financial price target lowered to $87 from $92 at Barclays
- Voya Financial re-initiated with an Outperform at Keefe Bruyette
- Voya brings full administration of PFML, STD claims in house